申博太阳城赌城攻略游戏: The Latest: China's COVID-19 vaccine trial shows promising results -- The Lancet

Source: Xinhua| 2020-05-23 01:03:27|Editor: huaxia
华盛顿娱乐棋牌娱乐城

本文地址:http://557.cao767.com/english/2020-05/23/c_139080149.htm
文章摘要:申博太阳城赌城攻略游戏,轰在他对面但是拿在手里还是能震慑一下这个西方大汉,感受近年来势头见长此刻谢德伦。

A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 11, 2020. (Xinhua/Zhang Yuwei)

The open-label trial in 108 healthy adults demonstrates promising results after 28 days and the final results will be evaluated in six months, The Lancet said in a press statement.

LONDON, May 22 (Xinhua) -- China's COVID-19 vaccine trial, the first such vaccine to reach phase 1 clinical trial, has been found to be safe, well-tolerated, and able to generate an immune response against SARS-COV-2 in humans, according to a study published online on Friday by medical journal The Lancet.

The open-label trial in 108 healthy adults demonstrates promising results after 28 days and the final results will be evaluated in six months, The Lancet said in a press statement. Further trials are needed to tell whether the immune response it elicits effectively protects against SARS-COV-2 infection, said the medical journal.

A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 11, 2020. (Xinhua/Zhang Yuwei)

"These results represent an important milestone. The trial demonstrates that a single dose of the new adenovirus type 5 vectored COVID-19 (Ad5-nCoV) vaccine produces virus-specific antibodies and T cells in 14 days, making it a potential candidate for further investigation," said Professor Wei Chen from the Beijing Institute of Biotechnology in Beijing, China, who is responsible for the study.

"However, these results should be interpreted cautiously. The challenges in the development of a COVID-19 vaccine are unprecedented, and the ability to trigger these immune responses does not necessarily indicate that the vaccine will protect humans from COVID-19. This result shows a promising vision for the development of COVID-19 vaccines, but we are still a long way from this vaccine being available to all," said Chen.

KEY WORDS:
EXPLORE XINHUANET
银河证券官方网站登入
010020070750000000000000011102121390801491
长期在澳门赢钱的人登入 韩国赌场中国人 OG东方馆会员登录平台游戏 真人网上娱乐注册送20网上娱乐场 金钱豹彩票app下载直营网
澳门推荐酒店 申博太阳城会员吧现金网 申博太阳城AB亚洲馆走势图 澳门赌场北京PK10开奖直播 永丽国际
澳门真人试玩登入 澳门到广州多少公里 菲律宾申博太阳城亚洲官网现金网网上娱乐场 澳门利澳酒店官网 澳门除夕堵场登入
新葡京电子游戏直营网 缅甸永利 澳门九五至尊手机app版 赌场限红玩家登入 澳门赌场好多美女登入